269 related articles for article (PubMed ID: 27236706)
1. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
[TBL] [Abstract][Full Text] [Related]
2. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.
Hasturk H; Abdallah R; Kantarci A; Nguyen D; Giordano N; Hamilton J; Van Dyke TE
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1123-33. PubMed ID: 25792445
[TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
[TBL] [Abstract][Full Text] [Related]
6. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
[TBL] [Abstract][Full Text] [Related]
7. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro.
Salas-Hernández A; Espinoza-Pérez C; Vivar R; Espitia-Corredor J; Lillo J; Parra-Flores P; Sánchez-Ferrer CF; Peiró C; Díaz-Araya G
Mol Biol Rep; 2021 Jan; 48(1):57-66. PubMed ID: 33459958
[TBL] [Abstract][Full Text] [Related]
9. Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition.
Tie C; Gao K; Zhang N; Zhang S; Shen J; Xie X; Wang JA
PLoS One; 2015; 10(11):e0142430. PubMed ID: 26555472
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
[TBL] [Abstract][Full Text] [Related]
11. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN
J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090
[TBL] [Abstract][Full Text] [Related]
12. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
Arita M; Bianchini F; Aliberti J; Sher A; Chiang N; Hong S; Yang R; Petasis NA; Serhan CN
J Exp Med; 2005 Mar; 201(5):713-22. PubMed ID: 15753205
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
14. Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin.
Ekstrand M; Gustafsson Trajkovska M; Perman-Sundelin J; Fogelstrand P; Adiels M; Johansson M; Mattsson-Hultén L; Borén J; Levin M
PLoS One; 2015; 10(6):e0130898. PubMed ID: 26098110
[TBL] [Abstract][Full Text] [Related]
15. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.
Harrison JL; Rowe RK; Ellis TW; Yee NS; O'Hara BF; Adelson PD; Lifshitz J
Brain Behav Immun; 2015 Jul; 47():131-40. PubMed ID: 25585137
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice.
Eussen SR; Rompelberg CJ; Andersson KE; Klungel OH; Hellstrand P; Oste R; van Kranen H; Garssen J
Pharmacol Res; 2011 Jul; 64(1):36-43. PubMed ID: 21371558
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Kim TH; Kim GD; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2012 Dec; 14(4):384-91. PubMed ID: 22951188
[TBL] [Abstract][Full Text] [Related]
19. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.
Qu X; Zhang X; Yao J; Song J; Nikolic-Paterson DJ; Li J
J Pathol; 2012 Dec; 228(4):506-19. PubMed ID: 22610993
[TBL] [Abstract][Full Text] [Related]
20. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
Kantarci A; Aytan N; Palaska I; Stephens D; Crabtree L; Benincasa C; Jenkins BG; Carreras I; Dedeoglu A
Exp Neurol; 2018 Feb; 300():111-120. PubMed ID: 29126887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
